Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma

Cancer Research

Volumn 58, Issue 20, 1998, Pages 4701-4707

  Varella Garcia, Marileila ^a   Gemmill, Robert M ^a   Rabenhorst, Silvia H ^a   Lotto, Alice ^b   Drabkin, Harry A ^a   Archer, Philip A ^b   Franklin, Wilbur A ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 3; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; FLUORESCENCE IN SITU HYBRIDIZATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL;

ACID ANHYDRIDE HYDROLASES; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOMES, HUMAN, PAIR 3; GENE DUPLICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; NEOPLASM PROTEINS; PROTEINS;

EID: 0032532657     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Kok, K., Naylor, S. L., and Buys, C. H. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv. Cancer Res., 71: 27-92, 1997.
2. Miura, I., Siegfried, J. M., Resau, J., Keller, S. M., Zhou, J. Y., and Testa, J. R. Chromosome alterations in 21 non-small cell lung carcinomas. Genes Chromosomes Cancer, 2: 328-338, 1990.
3. Whang-Peng, J., Knutsen, T., Gazdar, A., Steinberg, S. M., Oie, H., Linnoila, I., Mulshine, J., Nau, M., and Minna, J. D. Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer. Genes Chromosomes Cancer, 3: 168-188, 1991.
4. Law, E., Gilvarry, U., Lynch, V., Gregory, B., Grant, G., and Clynes, M. Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines. Cancer Genet. Cytogenet., 59: 111-118, 1992.
5. Testa, J. R., and Siegfried, J. M. Chromosome abnormalities in human non-small cell lung cancer. Cancer Res., 52: 2702s-2706s, 1992.
6. Testa, J. R., Siegfried, J. M., Liu, Z., Hunt, J. D., Feder, M. M., Litwin, S., Zhou, J. Y., Taguchi, T., and Keller, S. M. Cytogenetic analysis of 63 non-small cell lung carcinomas: recurrent chromosome alterations amid frequent and widespread genomic upheaval. Genes Chromosomes Cancer. 11: 178-194, 1994.
7. Matturri, L., and Lavezzi, A. M. Recurrent chromosome alterations in non-small cell lung cancer. Eur. J. Histochem., 38: 53-58, 1994.
8. Brauch, H., Johnson, B., Hovis, J., Yano, T., Gazdar, A., Pettengill, O. S., Graziano, S., Sorenson, G. D., Poiesz, B. J., and Minna, J. D. Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. N. Engl. J. Med., 317: 1109-1113, 1987.
9. Kok, K., Osinga, J., Carritt, B., Davis, M. B., van der Hout, van der Veen, A. Y., Landsvater, R. M., de Leij, L. F., Berendsen, H. H., Postmus, P. E., Poppema, S., and Buys, C.H.C.M. Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature (Lond.), 330: 578-581, 1987.
10. Yokota, J., Wada, M., Shimosato, Y., Terada, M., and Sugimura, T. Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA, 84: 9252-9256, 1987.
11. Rabbitts, P., Douglas, J., Daly, M., Sundaresan, V., Fox, B., Haselton, P., Wells, F., Albertson, D., Waters, J., and Bergh, J. Frequency and extent of allelic loss in the short arm of chromosome 3 in non-small cell lung cancer. Genes Chromosomes Cancer, 1: 95-105, 1989.
12. Weston, A., Willey, J. C. Modali, R., Sugimura, H., McDowell, E. M., Resau, J., Light, B., Haugen, A., Mann, D. L., and Trump, B. F. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. Proc. Natl. Acad. Sci. USA, 86: 5099-5103, 1989.
13. Yokoyama, S., Yamakawa, K., Tsuchiya, E., Murata, M., Sakiyama, S., and Nakamura, Y. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res., 52: 873-877, 1992.
14. Hibi, K., Takahashi, T., Yamakawa, K., Ueda, R., Sekido, Y., Ariyoshi, Y., Suyama, M., Takagi, H., and Nakamura, Y. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene, 7: 445-449, 1992.
15. Hosoe, S., Shigedo, Y., Ueno, K., Tachibana, L, Osaki, T., Tanio, Y., Kawase, I., Yamakawa, K., Nakamura, Y., and Kishimoto, T. Detailed deletion mapping of the short arm of chromosome 3 in small cell and non-small cell carcinoma of the lung. Lung Cancer, 10: 297-305, 1994.
16. Tsuchiya, E., Nakamura, Y., Weng, S. Y., Nakagawa, K., Tsuchiya, S., Sugano, H., and Kitagawa, T. Allelotype of non-small cell lung carcinoma-comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res., 52: 2478-2481, 1992.
17. Todd, S., Franklin, W. A., Varella-Garcia, M., Kennedy, T., Hilliker, C. E. J., Hahner, L., Anderson, M., Wiest, J. S., Drabkin, H. A., and Gemmill, R. M. Homozygous deletions of human chromosome 3p in lung tumors. Cancer Res., 57: 1344-1352, 1997.
18. Sozzi, G., Miozzo, M., Tagliabue, E., Calderone, C., Lombardi, L., Pilotti, S., Pastorino, U., Pierotti, M. A., and Della Porta, G. Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res., 51: 400-404, 1991.
19. Sundaresan, V., Ganly, P., Haselton, P., Rudd, R., Sinha, G., Bleehen, N. M., and Rabbitts, P. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene, 7: 1989-1997, 1992.
20. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., McIntire, D. D., Minna, J. D., and Gazdar, A. F. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma [published erratum appears in J. Am. Med. Assoc., 273: 1908, 1995]. J. Am. Med. Assoc., 273: 558-563, 1995.
21. Shiseki, M., Kohno, T., Adachi, J., Okazaki, T., Otsuka, T., Mizoguchi, H., Noguchi, M., Hirohashi, S., and Yokota, J. Comparative allelotype of early and advanced stage non-small cell lung carcinomas. Genes Chromosomes Cancer, 17: 71-77, 1996.
22. Fong, K. M., Biesterveld, E. J., Virmani, A., Wistuba, I., Sekido, Y., Bader, S. A., Ahmadian, M., Ong, S. T., Rassool, F. V., Zimmerman, P. V., Giaccone, G., Gazdar, A. F., and Minna, J. D. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res., 57: 2256-2267, 1997.
23. Junker, K., Thomas, M., Schulmann, K., Klinke, F., Bosse, U., and Muller, K. M. Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment. J. Cancer Res. Clin. Oncol., 123: 469-477, 1997.
24. Volm, M., Drings, P., Mattern, J., Sonka, J., Vogt-Moykopf, I., and Wayss, K. Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma. Cancer (Phila.), 56: 1396-1403, 1985.
25. Volm, M., Mattern, J., Sonka, J., Vogt-Schaden, M., and Wayss, K. DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior. Cytometry, 6: 348-356, 1985.
26. Cibas, E. S., Melamed, M. R., Zaman, M. B., and Kimmel, M. The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung. Cancer (Phila.), 63: 1552-1556, 1989.
27. Salvati, F., Teodori, L., Gagliardi, L., Signera, M., Aquilini, M., and Storniello, G. DNA flow cytometric studies of 66 human lung tumors analyzed before treatment. Prognostic implications. Chest, 96: 1092-1098, 1989.
28. Stipa, S., Danesi, D. T., Modini, C., Cicconetti, F., Mauro, F., Schillaci, A., Mecozzi, A., Nicolanti, V., Stipa, F., and Mancini, M. The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometry. Surg. Gynecol. Obstet., 176: 427-434, 1993.
29. Rice, T. W., Bauer, T. W., Gephardt, G. N., Medendorp, S. V., McLain, D. A., and Kirby, T. J. Prognostic significance of flow cytometry in non-small-cell lung cancer. J. Thorac. Cardiovasc. Surg., 106: 210-217, 1993.
30. Salvati, F., Teodori, L., Trinca, M. L., Pasquali-Lasagni, R., and Gohde, W. The relevance of flow-cytometric DNA content in the evaluation of lung cancer. J. Cancer Res. Clin. Oncol., 120: 233-239, 1994.
31. Dalquen, P., Moch, H., Feichter, G., Lehmann, M., Soler, M., Stulz, P., Jordan, P., Torhorst, J., Mihatsch, M. J., and Sauter, G. DNA aneuploidy, S-phase fraction, nuclear p53 positivity, and survival in non-small-cell lung carcinoma. Virchows Arch., 431: 173-179, 1997.
32. Schenk, T., Ackermann, J., Brunner,. C., Schenk, P., Zojer, N., Roka, S., and Drach, J. Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients. Chest. 111: 1691-1696, 1997.
33. Boldog, F., Gemmill, R. M., West, J., Robinson, M., Robinson, L., Li, E., Roche, J., Todd, S., Waggoner, B., Lundstrom, R., Jacobson, J., Mullokandov, M. R., Klinger, H., and Drabkin, H. A. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum. Mol. Genet., 6: 193-203, 1997.
34. Roche, J., Boldog, F., Robinson, M., Robinson, L., Varella-Garcia, M., Swanton, M., Waggoner, B., Fishel, R., Franklin, W., Gemmill, R., and Drabkin, H. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. Oncogene, 12: 1289-1297, 1996.
35. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbor Laboratory, 1989.
36. Johansson, M., Jin, Y., Mandahl, N., Hambraeus, G., Johansson, L., Mitelman, F., and Heim, S. Cytogenetic analysis of short-term cultured squamous cell carcinomas of the lung. Cancer Genet. Cytogenet., 81: 46-55, 1995.
37. Lukeis, R., Ball, D., Irving, L., Garson, O. M., and Hasthorpe, S. Chromosome abnormalities in non-small cell lung cancer pleural effusions: cytogenetic indicators of disease subgroups. Genes Chromosomes Cancer, 8: 262-269, 1993.
38. Whang-Peng, J., Kao-Shan, C. S., Lee, E. C., Bunn, P. A., Carney, D. N., Gazdar, A. F., and Minna, J. D. Specific chromosome defect associated with human small-cell lung cancer: deletion 3p(14-23). Science (Washington DC). 215: 181-182, 1982.
39. Whang-Peng, J., Bunn, P. A., Jr., Kao-Shan, C. S., Lee, E. C., Carney, D. N., Gazdar, A., and Minna, J. D. A nonrandom chromosomal abnormality, del 3p(14-23), in human small cell lung cancer (SCLC). Cancer Genet. Cytogenet., 6: 119-134, 1982.
40. Dutrillaux, B. Pathways of chromosome alteration in human epithelial cancers. Adv. Cancer Res., 67: 59-82, 1995.
41. Muleris, M., Delattre, O., Olschwang, S., Dutrillaux, A. M., Remvikos, Y., Salmon, R. J., Thomas, G., and Dutrillaux, B. Cytogenetic and molecular approaches of polyploidization in colorectal adenocarcinomas. Cancer Genet. Cytogenet., 44: 107-118, 1990.
42. Muleris, M., Salmon, R. J., and Dutrillaux, B. Cytogenetics of colorectal adenocarcinomas. Cancer Genet. Cytogenet., 46: 143-156, 1990.
43. Drouin, V., Viguie, F., and Debesse, B. Near-haploid karyotype in a squamous cell lung carcinoma. Genes Chromosomes Cancer. 7: 209-212, 1993.
44. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types [see comments]. Science (Washington DC), 264: 436-440, 1994.
45. Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J. L., Buckler, A., Gabrielson, E., Tockman, M, Cho, K. R., Hedrick, L., Bova, G. S., Isaacs, W., Koch, W., Schwab, D., and Sidransky, D. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet., 11: 210-212, 1995.
46. Washimi, O., Nagatake, M., Osada, H., Ueda, R., Koshikawa, T., Seki, T., and Takahashi, T. In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers. Cancer Res., 55: 514-517, 1995.
47. Wiest, J. S., Franklin, W. A., Otstot, J. T., Forbey, K., Varella-Garcia, M., Rao, K., Drabkin, H., Gemmill, R., Ahrent, S., Sidransky, D., Saccomanno, G., Fountain, J. W., and Anderson, M. W. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. Cancer Res., 57: 1-6, 1997.
48. Kishimoto, Y., Murakami, Y., Shiraishi, M., Hayashi, K., and Sekiya, T. Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res., 52: 4799-4804, 1992.
49. Hensel, C. H., Hsieh, C. L., Gazdar, A. F., Johnson, B. E., Sakaguchi, A. Y., Naylor, S. L., Lee, W. H., and Lee, E. Y. Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res., 50: 3067-3072, 1990.
50. Wieland, I., and Bohm, M. Frequent allelic deletion at a novel locus on chromosome 5 in human lung cancer. Cancer Res., 54: 1772-1774, 1994.
51. Todd, S., Franklin, W. A., Varella-Garcia, M., Kennedy, T., Hilliker, C. E., Hahner, L., Drabkin, H. A., Anderson, M., Wiest, J. S., and Gemmill, R. M. Homozygous deletions of chromosome 3p in lung tumors. Cancer Res., 57: 1344-1352, 1997.
52. Mao, L., Lee, J. S., Kurie, J. M., Fan, Y. H., Lippman, S. M., Lee, J. J., Ro, J. Y., Broxson, A., Yu, R., Morice, R. C. Kemp, B. L. Khuri, F. R., Walsh, G. L., Hittelman, W. N., and Hong, W. K. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst., 89: 857-862, 1997.
53. Sozzi, G., Sard, L., De Gregorio, L., Marchelti, A., Musso, K., Buttitta, F., Tornielli, S., Pellegrini, S., Veronese, M. L., Manenti, G., Incarbone, M., Chella, A., Angeletti, C. A., Pastorino, U., Huebner, K., Bevilaqua, G., Pilotti, S., Croce, C. M., and Pierotti, M. A. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res., 57: 2121-2123, 1997.
54. Glover, T. W., Berger, C., Coyle, J., and Echo, B. DNA polymerase a inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet., 67: 136-142, 1984.
55. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mon, M., McCue, P., Druck, T., Croce, C., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
56. Sozzi, G., Veronese, M. L., Negrini, M., Baffa, R., Cotticelli, M. G., Inoue, H., Tornielli, S., Pilotti, S., De Gregorio, L., Pastorino, U., Pierotti, M. A., Ohta, M., Huebner, K., and Croce, C. M. The FHIT gene 3p14.2 is abnormal in lung cancer. Cell, 85: 17-26, 1996.
57. Siprashvili, Z., Sozzi, G., Barnes, L. G., McCue, P., Robinson, A. K., Eryomin, V., Sard, L., Tagliabue, E., Greco, A., Fusetti, L., Schwartz, G., Pierotti, M. A., Croce, C. M., and Huebner, K. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc. Natl. Acad. Sci. USA, 94: 13771-13776, 1997.
58. Otterson, G. A., Xiao, G. H., Geradts, J., Jin, F., Chen, W. D., Niklinska, W., Kaye, F. J., and Yeung, R. S. Protein expression and functional analysis of the FHIT gene in human tumor cells. J. Natl. Cancer Inst., 90: 426-432, 1998.
59. Daly, M. C., Xiang, R. H., Buchhagen, D., Hensel, C. H., Garcia, D. K., Killary, A. M., Minna, J. D., and Naylor, S. L. A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity. Oncogene, 8: 1721-1729, 1993.
60. Kok, K., van den Berg, A., Veldhuis, P. M., van der Veen, A. Y., Franke, M., Schoenmakers, E. F., Hulsbeek, M. M., van der Hout, A. H., De Leij, L., van de Yen, W., and Buys, C.H.C.M. A homozygous deletion in a small cell lung cancer cell line involving a 3p21 region with a marked instability in yeast artificial chromosomes. Cancer Res., 54: 4183-4187, 1994.
61. Lerman, M. I., Latif, F., Glenn, G. M., Daniel, L. N., Brauch, H., Hosoe, S., Hampsch, K., Delisio, J., Orcutt, M. L., McBride, O. W., et al. Isolation and regional localization of a large collection (2,000) of single-copy DNA fragments on human chromosome 3 for mapping and cloning tumor suppressor genes. Hum. Genet., 86: 567-577, 1991.
62. Wei, M. H., Latif, F., Bader, S., Kashuba, V., Chen, J. Y., Duh, F. M., Sekido, Y., Lee, C. C, Geil, L., Kuzmin, I., Zabarovsky, E., Klein, G., Zbar, B., Minna, J. D., and Lerman, M. I. Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolalion of a lung cancer TSG. Cancer Res., 56: 1487-1492, 1996.
63. Blatt, C., Eversole-Cire, P., Cohn, V. H., Zollman, S., Foumier, R. E., Mohandas, L. T., Nesbitt, M., Lugo, T., Jones, D. T., and Reed, R. R. Chromosomal localization of genes encoding guanine nucleotide-binding protein subunits in mouse and human. Proc. Natl. Acad. Sci. USA, 85: 7642-7646, 1988.
64. Magovcevic, I., Ang, S. L., Seidman, J. G., Tolman, C. J., Neer, E. J., and Morton, C. C. Regional localization of the human G protein αi2 (GNA12) gene: assignment to 3p21 and a related sequence (GNAI2L) to 12p12-p13. Genomics, 12: 125-129, 1992.
65. Sithanandam, G., Latif, F., Duh, F. M., Bernai, R., Smola, U., Li, H., Kuzmin, L. Wixler, V., Geil, L., and Shrestha, S. 3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region [published erratum appears in Mol. Cell. Biol., 16: 1880, 1996]. Mol. Cell Biol., 16: 868-876, 1996.
66. Xiang, R. H., Hensel, C. H., Garcia, D. K., Carlson, H. C., Kok, K., Daly, M. C., Kerbacher, K., van den Berg, A., Veldhuis, P., Buys, C. H., and Naylor, S. L. Isolation of the human semaphorin III/F gene (SEMASF) at chromosome 3p21, a region deleted in lung cancer. Genomics, 32: 39-48, 1996.
67. Sekido, Y., Bader, S., Latif, F., Chen, J. Y., Duh, F. M., Wei, M. H., Albanesi, J. P., Lee, C. C., Lerman, M. I., and Minna, J. D. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc. Natl. Acad. Sci. USA, 93: 4120-4125, 1996.